Pharmaceutical Business review

FDA clears Teva Women’s contraceptive medication for over-the-counter sale

Plan B One-Step will become the first contraceptive to be available in the Family Planning Aisle in Stores across the country.

Teva Women’s Health US Brand Pharmaceuticals vice president and general manager Marty Berndt said, "Today, we welcome the FDA’s decision to provide extended and improved access to this important product, a significant milestone for women."

Strict age verification procedures will be followed at the retail for the sale of Plan B One-Step, which is not an abortifacient and do not harm existing pregnancy.

The progestin-only emergency contraceptive is developed to prevent pregnancy when administered 72 hours following birth control failure or unprotected sex, according to the company.